Quantitative bioluminescent method appropriate for bimodality analysis to improve and follow a syngenic murine model of B-cell lymphoma expressing human CD20

被引：0

|

作者：

Dayde, David ^{[1
]}

Dommange, Florence ^{[1
]}

Lerondel, Stephanie ^{[2
]}

Golay, Josee ^{[3
]}

Le Pape, Alain ^{[2
]}

Paintaud, Gilles ^{[1
]}

Bardos, Pierre ^{[1
]}

Watier, Herve ^{[1
]}

Cartron, Guillaume ^{[4
]}

Rossi, Jean-Francois ^{[1
]}

机构：

[1] Univ Tours, EA3853, Immuno Pharmaco Genet Therapeut Antibodies, Tours, France

[2] Ctr Distribut Typage Archivage Anim, Serv Imagerie Fonctionnelle, Orleans, France

[3] Osped Riuniti Bergamo, Lab Cellular & Gene Therapy, Bergamo, Italy

[4] CHU Lapeyronie, INSERM, U847, Serv Hematol & Biotherapies, Montpellier, France

来源：

BLOOD | 2007年 / 110卷 / 11期

关键词：

D O I：

10.1182/blood.V110.11.1400.1400

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1400

引用

收藏

页码：420A / 420A

页数：1

相关论文

共 33 条

[31] Activity of ofatumumab (OFA), a fully human monoclonal antibody targeting CD20, against rituximab (RTX)-sensitive (RSCL) and rituximab-resistant cell lines (RRCL), in vivo, and primary tumor cells derived from patients with B-cell lymphoma.
Barth, M. J.
Hernandez-Ilizaliturri, F. J.
Mavis, C.
Tsai, P.
Gibbs, J. F.
Czuczman, M. S.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[32] R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by stem cell transplantation and maintenance treatment with rituximab or not: First interim analysis on 200 patients. CORAL study
Gisselbrecht, Christian
Schmitz, Norbert
Mounier, Nicolas
Ma, David
Tmeny, Marek
Hagberg, Hans
Linch, David C.
Shpilberg, Ofer
Ketterer, Nicolas
Glass, Bertram
Bosly, Andre
Gill, Devinder
Gaulard, Philippe
Moskowitz, Craig
BLOOD, 2007, 110 (11) : 159A - 159A
[33] Ofatumumab, a Fully Human Monoclonal Antibody Targeting CD20, Demonstrates Activity Against and Potentiates the Anti-Tumor Activity of Chemotherapy Agents In Rituximab-Sensitive Cell Lines (RSCL), Rituximab-Resistant Cell Lines (RRCL), Lymphoma Xenografts, and Primary Tumor Cells Derived From Patients with B-Cell Non-Hodgkin Lymphoma (NHL)
Barth, Matthew
Hernandez-Ilizaliturri, Francisco J.
Mavis, Cory
Tsai, Ping-Chiao
Gibbs, John
Deeb, George
Czuczman, Myron S.
BLOOD, 2010, 116 (21) : 1598 - 1598

← 1 2 3 4 →